hotline:
17715390137
Tel/Wechat:
18101240246 (Technology)
0512-68565571
Email:mxenes@163.com (Sales Engineer)bkxc.bonnie@gmail.com
Scan the code to follow or search the official account on WeChat:
2D Materials Fronrier After paying attention,
click on the lower right corner to contact us,
Enter enterprise WeChat.
Professional Services Online
已传文件:photo/1772675758.png
Abstract:
This study addresses the issues of difficulty in maintaining the homeostasis of bone marrow organoids and the unclear efficacy of tissue regeneration. By leveraging the bioactivity of silicate biomaterials and combining calcium silicate nanowires and magnesium silicate nanospheres, functional bone marrow organoids were constructed in a limited chemical composition culture medium. It was confirmed that these organoids can maintain structural homeostasis, optimize cell functions, and achieve enhanced tissue regeneration in a bone cartilage repair model. This study revealed the regulatory role of silicate biomaterials on bone marrow organoids and provided a new strategy for tissue regeneration.
01 Research Background
Bone marrow plays a central role in immune regulation, hematopoiesis, and the maintenance of the skeletal system. Bone marrow organoids offer a new direction for bone-related injury repair. However, current bone marrow organoids face core problems such as difficulty in maintaining homeostasis over the long term and unclear application effects of tissue regeneration. Silicate biomaterials can provide specific biochemical signals by releasing bioactive ions, enabling effective regulation of stem cell behavior and cell functions. This provides a feasible solution to these issues.
02 Main Content
The study utilized silicate biomaterials as a regulatory medium to conduct research on the construction and functional verification of functional bone marrow organoids, exploring the effects of the materials on the structural homeostasis and cell functions of bone marrow organoids, analyzing the role of the organoids in promoting key cells for regeneration, and verifying their application effects in bone cartilage tissue regeneration. It clarified the intrinsic association between silicate biomaterials and the functional enhancement of bone marrow organoids.
03 Research Design
Two silicate biomaterials, calcium silicate nanowires and magnesium silicate nanospheres, were selected. In a culture medium with clearly defined chemical components, mesenchymal stem cells and endothelial cells were co-cultured to engineer bone marrow organoids. Cell and molecular-level detection was used to analyze the structural and functional characteristics of the organoids, and their regenerative promotion effects were verified in an animal bone cartilage repair model.
04 Results
The prepared bone marrow organoids can stably preserve the endothelial network structure, enhance the self-renewal ability of mesenchymal components, and have a positive regulatory effect on hematopoietic stem cells. When co-cultured with regenerative-related cells, they can significantly increase the activity of chondrocytes, mesenchymal stem cells, and Schwann cells. Silicate biomaterials can upregulate the expression of genes related to bone formation and angiogenesis and the signaling pathways. Among them, the bone marrow organoids induced by magnesium silicate nanospheres can effectively promote the regeneration and repair of bone cartilage tissue.
05 Extension of Ideas
Based on the regulatory mechanism of silicate biomaterials on bone marrow organoids, the types of materials and microenvironmental regulation methods can be further expanded, deepening the interdisciplinary research between inorganic biomaterials and organoids. At the same time, this construction strategy can be extended to the development of more types of tissue organoids, enriching the basic research system and technical methods for tissue regeneration.
| Reminder: Beijing Beike New Material Technology Co., Ltd. supplies products only for scientific research, not for humans |
| All rights reserved © 2019 beijing beike new material Technology Co., Ltd 京ICP备16054715-2号 |